NCT03223610
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B-cell Lymphoma, +17 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Diffuse Large B-cell Lymphoma
Explore clinical trials studying Diffuse Large B-cell Lymphoma. Study availability and eligibility vary by location and protocol.
215 public trials
55 recruiting studies
Diffuse Large B-cell Lymphoma trial results
NCT05139017
- Conditions
- DLBCL, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) Glendale, Arizona, United States
- Beverly Hills Cancer Center ( Site 0184) Beverly Hills, California, United States
- Bass Medical Group ( Site 0166) Walnut Creek, California, United States
- Innovative Clinical Research Institute ( Site 0122) Whittier, California, United States
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- USA Mitchell Cancer Institute ( Site 0173) Mobile, Alabama, United States
- Banner MD Anderson Cancer Center ( Site 0165) Gilbert, Arizona, United States
- Banner MD Anderson Cancer Center - University Medical Center Phoenix ( Site 0167) Phoenix, Arizona, United States
- The University of Arizona Cancer Center - North Campus ( Site 0124) Tucson, Arizona, United States
Recruiting
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
NCT04002947
- Conditions
- DLBCL, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT07200375
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Cancer Hospital Chinese Academy of Medical Sciences. Langfang, Hebei, China
- Chinese Academy of Medical Sciences Hematology Hospital;Lymphoma Diagnosis and Treatment Center Tianjin, Tianjin Municipality, China
- Peking University People's Hospital Beijing, China
- Peking University Third Hospital Beijing, China
Recruiting
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
NCT05952024
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Research Site Berkeley, California, United States
- Research Site La Jolla, California, United States
- Research Site Orange, California, United States
- Research Site Stamford, Connecticut, United States
NCT07750886
- Conditions
- Anaplastic Large Cell Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Lymphoma, +22 more
- Locations
-
- Natera, Inc. Austin, Texas, United States
NCT01804686
- Conditions
- Blood Protein Disorders, Bronchial Diseases, Bronchiolitis, +43 more
- Locations
-
- City of Hope Cancer Center Duarte, California, United States
- University of California San Diego Medical Center La Jolla, California, United States
- University of California Los Angeles Los Angeles, California, United States
- St. Joseph Hospital Center for Cancer Prevention and Treatment Orange, California, United States
NCT06395103
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +32 more
- Locations
-
- Children's Hospital Los Angeles ( Site 1006) Los Angeles, California, United States
- Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016) Aurora, Colorado, United States
- Yale New Haven Hospital ( Site 1012) New Haven, Connecticut, United States
- Johns Hopkins All Children's Hospital ( Site 1025) St. Petersburg, Florida, United States
NCT06863402
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, +20 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States